Focus:

Sally Turner

All articles by Sally Turner

  1. Future of CRISPR

    Gene genie: can CRISPR-Cas9 deliver on its promise to transform genome therapy?

    CRISPR gene-editing therapy has been heralded as the highly sort after cure for multiple diseases including those affecting the liver…
    Read More…

    11 Apr
  2. drugs from corn

    Drugs from corn? Harvesting Mirexus’ phytoglycogen nano-particle

    Not so long ago, nanotechnology was still in the realms of science-fiction, but remarkably scientists are now creating new devices…
    Read More…

    8 Apr

  3. Christensella: the key to unlocking gut microbiome-based drug discovery?

    Progress in sequencing and metagenomics has made it possible to identify more than 2,000 new bacteria that inhabit the human…
    Read More…

    6 Mar

  4. Pat-INFORMED: the solution to drug patent procurement issues?

    Throughout the last decade, new treatments for HIV, hepatitis C, cancer and many other diseases have transformed the lives of…
    Read More…

    6 Dec

  5. Antimicrobial resistance: is pharmaceutical pollution creating superbugs?

    Antimicrobial resistance (AMR) is a major global health concern and pharmaceutical pollution is posing dangers to ecosystems and human health…
    Read More…

    3 Dec

  6. The Express Scripts story: super-pharmacies and the US drug industry

    With the cost of global healthcare soaring – and both Medicare and the National Health Service (NHS) under pressure to…
    Read More…

    22 Nov

  7. The problem with drug patents: can a new global approach help?

    Throughout the last decade, new treatments for HIV, hepatitis C, cancer and many other diseases have transformed the lives of…
    Read More…

    12 Nov

  8. Is the microbiome as important for precision medicine as genetics?

    As the microbiome can be evaluated through DNA sequencing and readily modified by targeted interventions, it has been suggested that…
    Read More…

    8 Nov

  9. Selling cells: the economics of CAR-T therapy

    Chimeric antigen receptor (CAR) T-cell therapy is developing at a significant pace and excitement about its potential is high. CAR-T…
    Read More…

    1 Nov

  10. Making clinical trials more transparent in the Americas

    Industry experts have been calling for public registration of clinical trials of drugs and medical devices since the 1980s, and…
    Read More…

    30 Oct

Go Top